NLS Pharmaceutics NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders. | ![]() Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2019 | Founding Date 2005 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Stans, CH HQ | Locations Rockville, US HQ |
Employees | Employees 6 | Employees 6527% increase |
Valuation ($) | Valuation ($) 10.2 m | Valuation ($) 1.9 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $719m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $74.6m (FY, 2025) |
Gross profit | Gross profit $2.5m (FY, 2024) | Gross profit $644.4m (FY, 2025) |
Net income | Net income ($2m) (FY, 2024) | Net income ($38.6m) (FY, 2025) |

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company